chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Aching in joints specifically the knees Stiffness in fingers and puffiness Headache behind the eyes Heart fluttering and weakness in legs Ringing in ears
Large oval patch (plaque?) rough around the border, smooth and paler color inside.  1" long.  Center of my back (I have a photo) I just noticed it yesterday. No treatments.
Pfizer COVID vaccine 6mo-4yr was diluted with sterile water instead of normal saline.
COVID 19; COVID 19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 58-year-old female patient received BNT162b2 (BNT162B2), on 17Aug2021 as dose 1, single (Lot number: FC3182), in left arm and on 07Sep2021 as dose 2, single (Lot number: FC3184) at the age of 56 years, in left arm for covid-19 immunisation. The patient's relevant medical history included: "COPD", start date: 2008 (ongoing); "Borderline hypertension" (unspecified if ongoing); "Fluid" (unspecified if ongoing); "Blood pressure" (unspecified if ongoing); "Prediabetes" (unspecified if ongoing). Concomitant medication(s) included: GLUCOCIL taken for glucose tolerance impaired (ongoing); HYDROCHLOROTHIAZIDE oral taken for hypertension, fluid imbalance, blood pressure measurement (ongoing). The following information was reported: DRUG INEFFECTIVE (medically significant), SUSPECTED COVID-19 (medically significant) all with onset 2021, outcome "unknown" and all described as "COVID 19".
Patient was setting down on a chair. Three minutes after the injection, he fell off the chair. I let him get up and asked him if he was okay. He said he is fine. At that moment, I follow our emergency protocol. Patient was verbal and I give him diphenhydramine 25 mg two capsules, 1 tablet of prednisone 50mg and an EpiPen 0.3mg injection. I called 911. Up on the EMS arrival he refuse to go with them to the hospital. He was fine talking to them and after their evaluation, they decided to le him go home. At the same time his brother came to pharmacy and took him home.
25MAY93 no fever; a little fussy; 26MAY93 grabbed back of rt side head said hurt x 1; 27AMy93 did same twice; 28MAY93 by 11AM had done same several times advised mom to contact MD;
Chills; Low grade fever (never got above 99); ZERO appetite; Tingly body; Odd nausea "ie". I didn't feel it in my stomach but in the back of my throat, verge of being sick and and knew that if had anything solid, would not digest it.; Mild sleepiness; Lethargy; Swollen lymph nodes; Illusive headache; Insomnia; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an unspecified route of administration in the left arm on 20Apr2021 at 18:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergic to sulfa antibiotics and lactose intolerance. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included vitamin b complex (MANUFACTURER UNKNOWN), iron (MANUFACTURER UNKNOWN), ergocalciferol (VITAMIN D) and montelukast sodium (SINGULAIR); all were taken for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the left arm on 23Mar2021 at 15:00 (at the age of 32-years-old) as a single dose for COVID-19 immunisation.  On 20Apr2021 at 18:30, the patient experienced chills, low grade fever (never got above 99) , zero appetite, tingly body, odd nausea where she didn't felt it in her stomach but in the back of her throat and it was like on the verge of being sick and knew that if it had anything solid which would not digest it, mild sleepiness and lethargy, swollen lymph nodes, illusive headache and insomnia. She also reported that most of that was immediately after the shot and only lasted a few hours. On the same day, the patient underwent body temperature test and the result was below 99 (unspecified units). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events chills, low grade fever (never got above 99), zero appetite, tingly body, odd nausea, mild sleepiness and lethargy, swollen lymph nodes, illusive headache and insomnia was recovering at the time of this report.     No follow-up attempts are needed. No further information is expected.
DUE TO THE DIFFENERENCE IN THE INTERVALS OF MODERNA AND PFIZER COVID VACCINES, WE HAD A FEW DAYS INWHICH SECOND DOSES OF BOTH VACCINES WERE BEING ADMINISTERED. THIS PATIENT WAS GIVEN THE CORRECT FORM,  INSTEAD OF RECEIVING HER SECOND DOSE OF MODERNA, SHE RECEIVED A DOSE OF PFIZER VACCINE. PT DID NOT SUFFER FROM ANY ADVERESE EVENT.  WE HAVE TAKEN STEPS TO AVOID THIS SITUATION IN THE FUTURE.
autoimmune hepatitis liver disease / development of autoimmune diseases; myocardial infarction / cardiac issues; pruritus / lesions across her body; vertigo / balance issues; This spontaneous report as received from a lawyer referring to a patient of unknown age and gender. The patient's relevant medical history, drug reactions/allergies and concomitant medication were not reported. On 08-JAN-2015, the patient was vaccinated with zoster vaccine live(ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster) (strength, route, dosage schedule, lot number and expiration date were not reported). On an unknown date, shortly after receiving zoster vaccine live(ZOSTAVAX) vaccine. Plaintiff suffered various health issues, including, but not limited to, lesions across her body, cardiac issues, vision problems, balance issues, and the development of autoimmune diseases. Specifically, Plaintiff was diagnosed with pruritus, myocardial infarction, vertigo, and autoimmune hepatitis liver disease. These injuries were caused by zoster vaccine live(ZOSTAVAX).  As a direct and proximate result, the plaintiff s symptoms have resulted in physical limitations not present before. Plaintiff also experienced mental and emotional distress due to resulting physical limitations and seriousness of her condition. Plaintiff sustained serious, progressive, severe and permanent personal injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment.   Upon internal review, the events were considered disabling; and myocardial infarction and autoimmune hepatitis were considered medically significant.
This spontaneous report as received from a healthcare worker refers to a 19 year old female patient. In August 2007 patient was vaccinated with first dose of GARDASIL 0.5 ml, intramuscular in the left deltoid, second dose was given on October 2007 and third dose was given in February 2008. No concomitant medication was reported. In August 2014 the patient was vaccinated with 4th dose of GARDASIL 0.5 ml, intramuscular in the left deltoid. No adverse effects were reported. Product quality complaint was not involved. The outcome of events was unknown. Additional information has been requested.
Redness, swelling, warmth at injection site. Swelling about 4 inches in diameter.
went to bed was moving around lot, mom check, pt was shackey, still asleep, was pale, sz disorder not ruled out;
MMR given right lower thigh, within 30 seconds pt presents local reaction where MMR was given. Pt presents 1 1/2-2" red patchy hives. MA administered 1 tsp Benadryl pt was monitored for 20 min. No further reaction seen. Pt to follow up with allergist.
lump in armpit of arm shot was taken in and extreme pain at lump that continues to last for days preventing any normal use of arm
Patient had swelling in her rt arm where vaccine was administered and she could not raise her arm without being in a lot of pain.
Sore arm with injection, raised bump 2 inches across, very sore spot in underarm, tired, fever for 12 hours. Took 2 Tylenol extra strength at 2pm and again at 10:30pm.
Severe episodes of atrial fibrillation began day after 2nd dose of Covid vaccine.  Prior to vaccine I had a history of Premature Atrial Contractions and Premature Ventricular Contractions, but for 2 years - no episodes of AF.  Severe episodes of AF continued from day 2 post second vaccine dose and continued for 3 weeks until my cardiologist prescribed amiodarone to control AF.
Patient received 2 mo vaccines at well-child check on Friday, 4/7. Evening of 4/7 (time unknown patient had a brief seizure-like episode followed by one episode of emesis prompting mother to call paramedics and patient was then taken to ER. Per mother, EMS thought episode (not witnessed by them) consistent with febrile seizure following vaccines. ED evaluation was very reassuring and patient was discharged with instructions for supportive care and to return with worsening. Morning of 4/8/17, patient was acting at baseline per mother. However, evening of 4/8/17, patient was increasingly fussy, acting as if in pain, and not as interactive as normal. Denied fever, further emesis, difficulty breathing, abnormal movements.
Shingrix - feels feverish, headache, body aches. He does not have a thermometer at time I'm filling this out, but says he feels like a low grade fever. 2nd dose shingles shot.
pain /achiness; shivering; tired; This case was reported by a consumer via call center representative and described the occurrence of pain in a 61-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included shingles (had shingles 30 years ago).   In September 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 3 months after receiving Shingrix, the patient experienced pain, shivering and tiredness. On an unknown date, the outcome of the pain, shivering and tiredness were unknown.   It was unknown if the reporter considered the pain, shivering and tiredness to be related to Shingrix.  Additional details were provided as follows: The patient received vaccine in the left arm. The patient administered vaccine in early September 2019. The patient had pain, shivering, tiredness and achiness. The reporter consented to follow up. For tolerance of 2nd dose refer case US2019204840.
Administer Expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) in a 42-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine). On 23-Nov-2021, EXPIRED PRODUCT ADMINISTERED (Administer Expired vaccine) had resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was provided. The vaccine was stored in freezer, pharmacist took out one to two vials and placed in fridge each day as needed. No treatment information was provided.
first vaccine 9/2/21 - unable to read that lot number; 2nd 9/23/21 - this is the best I can make out of the lot number  - the B could be a 13 - (the legible lot number of the vaccine given 9/23  is listed above )  fatigue and some memory struggles after the first one - these intensified following the 2nd vaccine to the point that family is concerned about early onset dementia ; she is confused, forgetful, repeating herself, forgetting to eat and losing items...
I learned I was pregnant the day after the first dose of my vaccine. Two and a half weeks after the second dose I experienced bleeding when my pregnancy was at seven weeks. I had spotting for two days. Two weeks after that I had heavier bleeding.  I thought my pregnancy was progressing but it was confirmed that the baby stopped growing at seven weeks. I should have been eleven and a half weeks pregnant at that time.  Due Date: 01/08/2022 Pregnancy: fourth
Shot # 1:  SICK FOR 6 WEEKS -  debilitating fatigue, pins & needles, stinging/burning jolts of head pain, gastro distress, respiratory problems, trouble swallowing.  Shot #2:  Fatigue for 6 days.  Two weeks post shot:  severe swallowing, chewing and speech impairment -- followed by  DIAGNOSIS OF MYASTHENIA GRAVIS.
Gastrointestinal discomfort, diarrhea began approximately 7:00 PM and continued for at least 3 hours (initially attributed by patient to food-induced indigestion) Fatigue, body ache, headache began approximately 8:30 PM and continued for approximately 36 hours Chills, probable low-grade fever (not measured) began approximately 9:30 PM and continued for 12-24 hours
Mild reaction / had chills; Mild reation / was a little feverish; Mild reaction / not being well; Mild reaction / Spent time in bed; This case was reported by a consumer and described the occurrence of chills in a 68-year-old female patient who received Herpes zoster (Shingrix) (batch number 4G5HX, expiry date 20th April 2020) for prophylaxis.   Previously administered products included pneumococcal vaccine with an associated reaction of nonspecific reaction (in 2018). Concurrent medical conditions included hypotension, drug allergy (Allergic to thimerosal, cilantro and codeine) and herbal allergy (cilantro). Concomitant products included medication unknown (Bioidentical Hormones (Generic Ingredient Unknown)).   On 19th April 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than 5 months after receiving Shingrix, the patient experienced chills, fever, unwell and mobility decreased. On an unknown date, the outcome of the chills, fever, unwell and mobility decreased were recovered/resolved.   The reporter considered the chills, fever, unwell and mobility decreased to be related to Shingrix.  Additional details were reported as follows: This case was reported by patient herself. The patient was healthy, had no kidney problems, no heart issues and exercises daily. The concomitant medication included thyroid medication. The patient received 1st dose of Shingrix and had mild reactions included chills, was a little feverish, not being well and spent time in bed. The patient that all these events were resolved. The patient stated that the expiration date listed for 1st dose was 20th April 2020 which does not match the expiration date in our system. [Note: pharmacies would often default to a 365 day expiration date]. The patient did not want to share her physician contact information (because the Shingrix injections were given at the pharmacy not the physician office). The reporter did not consent to follow-up. For tolerance of 2nd dose refer case US2021AMR010230.; Sender's Comments:  US-GLAXOSMITHKLINE-US2021AMR010230:Same patient, Same reporter. 2nd dose.
This spontaneous report as received from a Licensed Practical Nurse, refers to a female patient of unknown age. On 27-JUL-2013 the patient was vaccinated with a first dose of GARDASIL (intramuscular , 0.5 ml). The reporter stated that no date was documented in patient's chart for her second dose of GARDASIL and next documented date on patient's chart states that she was administered her third dose of GARDASIL (intramuscular, 0.5 ml) on 06-MAY-2013. Nurse stated that they are unsure if 3 doses of GARDASIL were in fact given to the patient or if only two doses of GARDASIL were given to the patient. No adverse effect reported. Additional information has been requested.
Patient described burning sensation down right arm and the back of neck. Observed skin blotching below the elbow on the right side.
Patient awoke this AM with rash described as "red, small dots", per patient's father. Rash present at face, trunk, & upper/lower extremities. Patient afebrile & denies pain or pruritis.
Child received Tdap and Dtap inadvertently instead of Tdap and MCV4. At this time no reactions, no local tissue changes. 2 hours afterwards child is well, he changes in health status.
Unwitnessed syncope vs possible seizure. Found down with ?shaking, ? apnea. Reportedly with some confusion briefly afterwards and then fully recovered.
Nausea, vomiting, diarrhea, muscle pain with fatigue with the first and second dose.  Was reported to not be able to hold anything down with second dose and  sudden death while sleeping (nap for fatigue).  Found dead in bed 3/21/2021.  No allergic reactions were reported.  No unusual electrolyte findings suggested the cause.
Symptom within 1 hour post vaccine Injection site pain  Symptoms 11 hours post vaccine Fatigue Swollen lymph under left arm (injection arm) Sore throat Headache Chills Feeling feverish  Symptoms 24 hours post vaccine Muscle aches Skin soreness Fever 102 - excessive sweats and chills Headache Sore throat Swollen lymphs in neck and under both arms Fatigue  Symptoms 48 hours post vaccine Injection site pain  Swollen lymph under injection arm Headache
Pt recvd MMR vax 3JUL91; on 6JUL91, while on vacation, devel photophobia, fever, h/a, stiff neck; hospitalized & dx w/aseptic meningitis; Additional info has been requested;
There does not appear to be any cause for her death. She passed away in her sleep. The only thing that happened that was different this year was that she received the Pfizer vaccine in April 2021.
Flulike symptoms, roughly 24 hours in duration: chills, fever, insomnia, headache, tiredness
3DEC98 nausea/vomiting/h/a;4DEC98 absent from school;pt exp nausea & vomiting yesterday;
First dose, sore arm within 12-36 hours, then no other symptoms until Day 6. I woke up at 6:30 with Vertigo. Never had it before and it is still going on 24 hours later.
Information has been received from the registered nurse concerning to an approximately 22 year old patient of unknown gender. Patient's concurrent conditions and relevant medical history was not reported. On 26-FEB-2015, the patient was vaccinated with improperly stored dose of GARDASIL (lot number: J012212 with expiration date of 18-FEB-2016)(dose, route and frequency unspecified). Concomitant medications were not reported. No adverse event was reported. The outcome of the event was unknown. The causality of the events with GARDASIL was not reported. This is one of the several reports from the same reporter.  Additional information has been requested.
Administered FLUZONE QUAD PFS to patient, seemed fine for 10 minutes afterward while giving rest of family vaccines. While around pharmacy for 10-15 minutes that we recommend, the patient began to feel dizzy, faint, and light-headed. Patient fell and cut his lip. Father and I sat the patient upright, we retrieved a trash bin in which the patient vomited. I asked for the patient's weight (58 lbs) and procured the Epi-pen Jr. The father and I observed the patient, watching for any signs of decreased breathing, throat/face swelling, or rash. Patient appeared pale and faint, however never lost consciousness or displayed signs of decreased breathing. I checked the patient's pulse and kept him focused on me. A pharmacy technician grabbed wet paper towels and applied to patients forehead.  After another few minutes, the patient began to regain color and was responding to questions. The father decided to walk around the pharmacy with the patient for another few minutes until they were ready to leave. I called the patient's father 20 minutes later to check in and the patient was fine.
Fatigue; Body aches; Headache; Injection site soreness; Brain fog; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN7533) via an unspecified route of administration in the left arm on 31Mar2021 at 12:15 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included sjogren's syndrome and arthritis. The patient had no known allergies to medications, food or other products. Prior to vaccination, patient was not diagnosed with COVID-19. Concomitant medications were not reported. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 10Mar2021 at 13:15 (at the age of 58-year-old) as a single dose for COVID-19 immunisation. On 31Mar2021 at 17:30 the patient experienced fatigue, body aches, headache, injection site soreness and brain fog. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fatigue, body aches, headache, injection site soreness and brain fog were recovered on an unknown date in 2021.  No follow-up attempts are needed. No further information is expected.
headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache) in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030M20A and 039K20A) for COVID-19 vaccination.     Concomitant products included SIMVASTATIN and HYDROCHLOROTHIAZIDE, TRIAMTERENE (TRIAMTERENE HCTZ) for an unknown indication.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced HEADACHE (headache). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (headache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
15 year old female c/o dizziness, HA with emesis starting approximately 4 d post hep A vacine administration. Symptoms progressively worsened with development of generalized weakness-vomited x 1d on 9/13/02 to 9/14/02 for further ? of symptoms-neurology consult in -house ? anxiety. Symptoms slowly improving to date.
I received the vaccine at local hospital. I had the previous injection of J&J in April 2021. I had an adverse reaction to the injection and was reported by my PCP. I had superficial clots on my right arm; the same side of the injection. The injection of the Moderna booster also resulted in blood clots on the left side, the same side of the injection. I was hospitalized from 01/05/2022 to 01/06/2022 at alternate local hospital to treat the five blood clots in my lungs.
Patient stated he had right arm pain radiating to the base of his skull and down entire arm.  Pain subsided by Monday and was replaced by numbness and tingling to entire extremity.